Results 101 to 110 of about 13,966 (231)

[Monoclonal gammopathy of undetermined significance with recurrent skin bleeding: a case report].

, 2022
Yue Xiao, Y Zhang, Chen Cao, Yun Luo, Shifeng Lou   +4 more
openalex   +2 more sources

What is the significance of monoclonal gammopathy of undetermined significance? [PDF]

, 2018
Catherine Atkin, Alex Richter, Elizabeth Sapey   +2 more
openalex   +1 more source

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance [PDF]

, 2005
S. Vincent Rajkumar, Robert A. Kyle, Terry M. Therneau, L. Joseph Melton, A.R. Bradwell, Raynell Clark, Dirk R. Larson, Matthew F. Plevak, Angela Dispenzieri, Jerry A. Katzmann   +9 more
openalex   +1 more source

Disease Associations With Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 17,398 Patients [PDF]

, 2009
John P. Bida, Robert A. Kyle, Terry M. Therneau, L. Joseph Melton, Matthew F. Plevak, Dirk R. Larson, Angela Dispenzieri, Jerry A. Katzmann, S. Vincent Rajkumar   +8 more
openalex   +1 more source

Additional file 2 of Progression patterns in monoclonal gammopathy of undetermined significance and multiple myeloma outcome: a cohort study in 42 patients

, 2022
Widad Tahiru, Antonio Izarra Santamaria, Johan Hultdin, Wendy Wu, Florentin Späth   +4 more
openalex   +1 more source

Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10–49 years old: a population-based study from the National Health and Nutrition Examination Survey [PDF]

, 2017
Ola Landgren, Barry I. Graubard, Shaji Kumar, Robert A. Kyle, J A Katzmann, Kazunori Murata, Rene Costello, Angela Dispenzieri, Neil E. Caporaso, Sham Mailankody, Neha Korde, Malin Hultcrantz, Terry M. Therneau, Dirk R. Larson, James R. Cerhan, S. Vincent Rajkumar   +15 more
openalex   +1 more source

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

The Lancet Haematology, 2023
Annie N. Cowan, F. Ferrari, S. Freeman, R. Redd, H. El-Khoury, Jacqueline Perry, Vidhi Patel, P. Kaur, Hadley Barr, David J Lee, Elizabeth D Lightbody, Katelyn Downey, D. Argyelan, F. Theodorakakou, D. Fotiou, C. Liacos, N. Kanellias, S. Chavda, L. Ainley, V. Sandecká, L. Pospisilova, J. Minařík, A. Jungová, J. Radocha, I. Špička, Omar Nadeem, K. Yong, R. Hájek, E. Kastritis, Catherine R. Marinac, M. Dimopoulos, Gad Get, L. Trippa, I. Ghobrial   +33 more
semanticscholar   +1 more source

Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises? [PDF]

, 2022
Stella Papachristou, Djordje S. Popovic, Νικόλαος Παπάνας   +2 more
openalex   +1 more source

IgM-.LAMBDA. type monoclonal gammopathy of undetermined significance showing non-specific Anti-Streptolysin 0 activity by a latex immumoaggregation method.

, 1999
Yukie Hanai, Tohru Takahashi, T Saito, Yumiko Kawahito, Kohji Senga, Fumie Kondo, Masamichi Isobe, Kohzoh Imai   +7 more
openalex   +2 more sources

Advances in the understanding of IgM monoclonal gammopathy of undetermined significance [PDF]

, 2017
Jonas Paludo, Stephen M. Ansell
openalex   +1 more source